CMS Entry id: 2710 | Channel: News landing page | Template: news/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

News

7 October 2020

Cambridge Cognition wins new digital health contract

Cambridge Cognition has won a new contract providing cognitive tests and electronic clinical outcome assessments for an Alzheimer’s trial. The total Contract is worth approximately £750,000 over two years, with a considerable proportion of the revenue for the Company expected to be received in 2021.

1 September 2020

Cambridge Cognition secures three late phase schizophrenia trials

Cambridge Cognition is pleased to announce that it has won a £2m contract as the cognitive assessment partner for three late phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia. It is one of the largest single contracts secured by the Company and the revenue from the contract should be booked over the next four years with the majority recognised in 2021.

15 July 2020

New virtual study to measure stress recovery in frontline health workers caring for COVID-19 patients

Cambridge Cognition is pleased to announce a collaboration with 4YouandMe and The Center for International Emergency Medical Services to investigate the utility of wearables and mobile phones for measuring stress recovery in frontline health workers caring for COVID-19 positive patients.

30 June 2020

Cambridge Cognition announces further contract wins in the first half of 2020

Further contract wins in the first half of 2020 takes the Company's order intake to £4.9m for the year to date. 

27 May 2020

CANTAB Research Grant 2020 - Results

The results of the 2020 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.

27 May 2020

Cambridge Cognition wins increasing numbers of virtual clinical trials during COVID-19

Cambridge Cognition is pleased to announce that the Company has recently won several new contracts to support pharmaceutical clients in delivering virtual clinical trials, including two contracts collectively worth over £1 million.